Azole-resistant Aspergillus fumigatus isolates carrying TR34/L98H mutations in Taiwan

Mycoses

Volumn 58, Issue 9, 2015, Pages 544-549

  Wu, Chi Jung ^a,b   Wang, Hsuan Chen ^a   Lee, Jen Chieh ^b   Lo, Hsiu Jung ^a   Dai, Ching Tzu ^c   Chou, Pei Hsin ^a   Ko, Wen Chien ^b   Chen, Yee Chun ^a,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aspergillus fumigatus; Azole fungicide; Azole resistance; Taiwan; TR34 L98H

Indexed keywords

ITRACONAZOLE; POSACONAZOLE; PYRROLE; VORICONAZOLE; ANTIFUNGAL AGENT; CYTOCHROME P-450 CYP51A, ASPERGILLUS; CYTOCHROME P450; FUNGAL PROTEIN; PYRROLE DERIVATIVE;

ADULT; AGED; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; AZOLE RESISTANT ASPERGILLUS FUMIGATUS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CROSS RESISTANCE; DYSPNEA; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LUNG ASPERGILLOSIS; LUNG LAVAGE; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; NONHUMAN; OUTCOME ASSESSMENT; PHYLOGENY; PRIORITY JOURNAL; TAIWAN; TEACHING HOSPITAL; DRUG EFFECTS; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MISSENSE MUTATION; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; MUTATION; PULMONARY ASPERGILLOSIS; RETROSPECTIVE STUDY; TIME FACTOR;

ASPERGILLUS FUMIGATUS;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, MULTIPLE, FUNGAL; FUNGAL PROTEINS; GENETIC VARIATION; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; PHYLOGENY; PULMONARY ASPERGILLOSIS; RETROSPECTIVE STUDIES; TAIWAN; TIME FACTORS;

EID: 84940438240     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12354     Document Type: Article

References (30)

1. Blyth CC, Gilroy NM, Guy SD et al. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 2014; 44: 1333-49.
2. Infectious Diseases Society of Taiwan, Hematology Society of Taiwan, Taiwan Society of Pulmonary and Critical Care Medicine, Medical Foundation in Memory of Dr Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education, CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. Guidelines for the use of antifungal agents in patients with invasive fungal infections in Taiwan - revised 2009. J Microbiol Immunol 2010; 43: 258-63.
3. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60.
4. Arendrup MC. Update on antifungal resistance in Aspergillus and Candida. Clin Microbiol Infect 2014; 20(Suppl): 42-8.
5. Chowdhary A, Kathuria S, Xu JP, Meis JF. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog 2013; 9: e1003633.
6. Van der Linden JW, Snelders E, Kampinga GA et al. Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009. Emerg Infect Dis 2011; 17: 1846-54.
7. Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 2009; 9: 789-95.
8. Snelders E, Camps SM, Karawajczyk A et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS ONE 2012; 7: e31801.
9. Chowdhary A, Kathuria S, Hagen F, Meis JF. Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia. Front Microbiol 2015; 6: 428.
10. Hsueh PR, Lau YJ, Chuang YC et al. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 2005; 49: 512-7.
11. Samson RA, Hong S, Peterson SW, Frisvad JC, Varga J. Polyphasic taxonomy of Aspergillus section Fumigati and its teleomorph Neosartorya. Stud Mycol 2007; 59: 147-203.
12. Patel R, Mendrick C, Knapp CC, Grist R, McNicholas PM. Clinical evaluation of the Sensititre YeastOne plate for testing susceptibility of filamentous fungi to posaconazole. J Clin Microbiol 2007; 45: 2000-1.
13. Castro C, Serrano MC, Flores B, Espinel-Ingroff A, Martin-Mazuelos E. Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp. J Clin Microbiol 2004; 42: 4358-60.
14. CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard-Second Edition. CLSI document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
15. Lass-Florl C. Susceptibility testing in Aspergillus species complex. Clin Microbiol Infect 2014; 20(Suppl): 49-53.
16. Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJ. Azole resistance profile of amino acid changes in Aspergillus fumigatus cyp51A based on protein homology modeling. Antimicrob Agents Chemother 2010; 54: 2425-30.
17. De Valk HA, Meis JF, Curfs IM, Muehlethaler K, Mouton JW, Klaassen CHW. Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J Clin Microbiol 2005; 43: 4112-20.
18. De Valk HA, Meis JF, Bretagne S et al. Interlaboratory reproducibility of a microsatellite-based typing assay for Aspergillus fumigatus through the use of allelic ladders: proof of concept. Clin Microbiol Infect 2009; 15: 180-7.
19. Kidd SE, Goeman E, Meis JF, Slavin MA, Verweij PE. Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses 2015; 58: 350-5.
20. 34/L98H mutations in the cyp51A gene in Iran. Mycoses 2013; 56: 659-63.
21. 34/L98H mutations in the cyp51A gene in India. PLoS ONE 2012; 7: e52871.
22. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
23. Chowdhary A, Sharma C, van den Boom M et al. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother 2014; 69: 2979-83.
24. 34/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother 2011; 55: 4465-8.
25. Stensvold CRJL, Arendrup MC. Azole-resistant invasive aspergillosis: relationship to agriculture. Curr Fungal Infect Rep 2012; 6: 178-91.
26. Taiwan Crop Protection Industry Association. Domestic manufacturers production & sale of pesticides in 2013. Taiwan Crop Protection Industry Association, Taipei, Taiwan, Republic of China. [In chinese]
27. Yang YL, Lin CC, Chang TP et al. Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole. PLoS ONE 2012; 7: e34609.
28. Pham CD, Reiss E, Hagen F, Meis JF, Lockhart SR. Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011-2013. Emerg Infect Dis 2014; 20: 1498-503.
29. Guinea J, Padilla C, Escribano P et al. Evaluation of MycAssay (TM) Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer. PLoS ONE 2013; 8: e61545.
30. Denning DW, Bowyer P. Voriconazole resistance in Aspergillus fumigatus: should we be concerned? Clin Infect Dis 2013; 57: 521-3.